Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for BD Coronavirus Test Kit

NEW YORK — The US Food and Drug Administration on Wednesday granted Emergency Use Authorization (EUA) for Becton Dickinson's PCR-based SARS-CoV-2 detection kit.

The kit is designed for the qualitative detection of nucleic acid from SARS-CoV-2 nasal, nasopharyngeal, and oropharyngeal swab samples. Nucleic acid is extracted using the company's BD MAX ExK TNA-3 kit, and the test runs on the BD Max system.

Use of the test is limited to CLIA-certified labs, the FDA said.

Last week, Franklin Lakes, New Jersey-based Becton Dickinson and BioGX received EUA from the FDA for a rapid hospital SARS-CoV-2 test that runs on the BD Max system.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.